A new study has found that use of low intensity bone marrow transplantation method shows promising results in patients with sickle cell disease. Myeloablative (use of high-dose chemotherapy or radiation) allogeneic hematopoietic stem cell transplantation (HSCT; receipt of hematopoietic stem cells "bone marrow" from another individual) is curative for children with severe sickle cell disease, but associated toxicity has made the procedure prohibitive for adults. ...
Read More
No comments:
Post a Comment